{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:18:46Z","timestamp":1777634326909,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T00:00:00Z","timestamp":1247616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/ejhg.2009.116","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T10:22:03Z","timestamp":1247653323000},"page":"52-58","source":"Crossref","is-referenced-by-count":50,"title":["SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR"],"prefix":"10.1038","volume":"18","author":[{"given":"Francesco Danilo","family":"Tiziano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Lomastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Pini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ghezzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Brahe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,15]]},"reference":[{"key":"BFejhg2009116_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","volume":"146","author":"K Zerres","year":"1997","unstructured":"Zerres K, Rudnik-Schoneborn S, Forrest E et al: A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci 1997; 146: 67\u201372.","journal-title":"J Neurol Sci"},{"key":"BFejhg2009116_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155\u2013165.","journal-title":"Cell"},{"key":"BFejhg2009116_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265\u2013269.","journal-title":"Nat Genet"},{"key":"BFejhg2009116_CR4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert DD, Le TT, McAndrew PE et al: The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6: 1205\u20131214.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009116_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.ejhg.5200286","volume":"7","author":"AL Patrizi","year":"1999","unstructured":"Patrizi AL, Tiziano F, Zappata S : SMN protein analysis in fibroblast, amniocyte, and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 1999; 7: 301\u2013309.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2009116_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R et al: Quantitative analysis of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358\u2013368.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2009116_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.nmd.2007.02.006","volume":"17","author":"FD Tiziano","year":"2007","unstructured":"Tiziano FD, Bertini E, Messina S et al: The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul Disord 2007; 17: 400\u2013403.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2009116_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"B Wirth","year":"2006","unstructured":"Wirth B, Brichta L, Schrank B et al: Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 2006; 119: 422\u2013428.","journal-title":"Hum Genet"},{"key":"BFejhg2009116_CR9","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"J-G Chang","year":"2001","unstructured":"Chang J-G, Hsieh-Li H-M, Jong Y-J et al: Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808\u20139813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009116_CR10","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E et al: Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481\u20132489.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009116_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647\u2013654.","journal-title":"Ann Neurol"},{"key":"BFejhg2009116_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","volume":"12","author":"C Andreassi","year":"2004","unstructured":"Andreassi C, Angelozzi C, Tiziano FD et al: Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 2004; 12: 59\u201365.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2009116_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","volume":"13","author":"C Brahe","year":"2005","unstructured":"Brahe C, Vitali T, Tiziano FD et al: Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet 2005; 13: 256\u2013259.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2009116_CR14","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ana.20836","volume":"59","author":"L Brichta","year":"2006","unstructured":"Brichta L, Holker I, Haug K : In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 2006; 59: 970\u2013975.","journal-title":"Ann Neurol"},{"key":"BFejhg2009116_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.20548","volume":"58","author":"SM Grzeschik","year":"2005","unstructured":"Grzeschik SM, Ganta M, Prior TW et al: Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 2005; 58: 194\u2013202.","journal-title":"Ann Neurol"},{"key":"BFejhg2009116_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","volume":"14","author":"J Jarecki","year":"2005","unstructured":"Jarecki J, Chen X, Bernardino A et al: Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum Mol Genet 2005; 14: 2003\u20132018.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009116_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jmg.2007.051177","volume":"45","author":"C Angelozzi","year":"2008","unstructured":"Angelozzi C, Borgo F, Tiziano FD : Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. J Med Genet 2008; 45: 29\u201331.","journal-title":"J Med Genet"},{"key":"BFejhg2009116_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.nmd.2008.05.004","volume":"18","author":"M Pane","year":"2008","unstructured":"Pane M, Staccioli S, Messina S et al: Daily salbutamol in young patients with SMA type II. Neuromuscul Disord 2008; 18: 536\u2013540.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2009116_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","volume":"68","author":"E Mercuri","year":"2007","unstructured":"Mercuri E, Bertini E, Messina S et al: Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology 2007; 68: 51\u201355.","journal-title":"Neurology"},{"key":"BFejhg2009116_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","volume":"67","author":"CC Weihl","year":"2006","unstructured":"Weihl CC, Connolly AM, Pestronk A : Valproate may improve strength and function in patients with type III\/IV spinal muscle atrophy. Neurology 2006; 67: 500\u2013501.","journal-title":"Neurology"},{"key":"BFejhg2009116_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jns.2007.11.012","volume":"268","author":"WC Liang","year":"2008","unstructured":"Liang WC, Yuo CY, Chang JG et al: The effect of hydroxyurea in spinal muscular atrophy cells and patients. J Neurol Sci 2008; 268: 87\u201394.","journal-title":"J Neurol Sci"},{"key":"BFejhg2009116_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","volume":"66","author":"CJ Sumner","year":"2006","unstructured":"Sumner CJ, Kolb SJ, Harmison GG et al: SMN mRNA and protein levels in peripheral blood. Neurology 2006; 66: 1067\u20131073.","journal-title":"Neurology"},{"key":"BFejhg2009116_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","volume":"68","author":"LR Simard","year":"2007","unstructured":"Simard LR, B\u00e9langer M-C, Morissette S et al: Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology 2007; 68: 451\u2013456.","journal-title":"Neurology"},{"key":"BFejhg2009116_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/sj.ejhg.5201885","volume":"15","author":"M Vezain","year":"2007","unstructured":"Vezain M, Saugier-Veber P, Melki J et al: A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Eur J Hum Genet 2007; 15: 1054\u20131062.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2009116_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2377-6-6","volume":"6","author":"SJ Kolb","year":"2006","unstructured":"Kolb SJ, Gubitz AK, Olszewski Jr RF et al: A novel cell immunoassay to measure survival of motor neurons protein in blood cells. BMC Neurol 2006; 6: 6.","journal-title":"BMC Neurol"},{"key":"BFejhg2009116_CR26","doi-asserted-by":"crossref","unstructured":"Thi Man N, Humphrey E, Lam LT et al: A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy. Neurology 2008. epub Fpage: ahead Misc: of print.","DOI":"10.1212\/01.wnl.0000313038.34337.b1"},{"key":"BFejhg2009116_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","volume":"7","author":"M Main","year":"2003","unstructured":"Main M, Kairon H, Mercuri E et al: The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol 2003; 7: 155\u2013159.","journal-title":"Eur J Paediatr Neurol"},{"key":"BFejhg2009116_CR28","first-page":"221","volume":"304","author":"M Gueudin","year":"2005","unstructured":"Gueudin M, Simon F : Plasma RNA viral load in HIV-1 group O infection by real-time PCR. Methods Mol Biol 2005; 304: 221\u2013228.","journal-title":"Methods Mol Biol"},{"key":"BFejhg2009116_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jcv.2004.03.009","volume":"31","author":"S Castelain","year":"2004","unstructured":"Castelain S, Descamps V, Thibault V et al: TaqMan amplification system with an internal positive control for HCV RNA quantitation. J Clin Virol 2004; 31: 227\u2013234.","journal-title":"J Clin Virol"},{"key":"BFejhg2009116_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0890-8508(02)00114-7","volume":"17","author":"A Tichopad","year":"2003","unstructured":"Tichopad A, Pfaffl MW, Didier A : Tissue-specific expression pattern of bovine prion gene: quantification using real-time RT-PCR. Mol Cell Probes 2003; 17: 5\u201310.","journal-title":"Mol Cell Probes"},{"key":"BFejhg2009116_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","volume":"114","author":"C Helmken","year":"2003","unstructured":"Helmken C, Hofmann Y, Schoenen F et al: Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003; 114: 11\u201321.","journal-title":"Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:57:23Z","timestamp":1684429043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2009116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFejhg2009116"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2009.116","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,15]]}}}